TipRanks
55% OFF
PC:TIMBE

Timberlyne Therapeutics

San Diego, California, United Statestimberlyne-tx.comTherapeutics

Timberlyne Therapeutics is a clinical-stage biopharmaceutical company dedicated to developing innovative therapies for autoimmune disorders. The company is advancing CM313, a monoclonal antibody targeting CD38, aimed at addressing diseases with high unmet medical needs. Formed through a partnership between Mountainfield Venture Partners and Keymed Biosciences, Timberlyne Therapeutics holds global development and commercial rights for CM313 outside of greater China.

Leadership & Board

Key Executives

Co-Founder
Christian Fougner
Current Number of Employees
7
Current LinkedIn Followers
3,155

Latest Estimated Valuation

Estimated Valuation
―
Total Amount Raised
$180M
Total Funding Rounds
1
Latest Funding Amount
$180M
Latest Funding Round
Series A
Post-Money Valuation
―

Employee Trend

Timberlyne Therapeutics had 7 employees as of October 12, 2026. The number of employees increased by 0 (0.00%) week-over-week.

7Latest Employee Count
0(0.00%)Week-Over-Week Change
05101520Dec 22, 2025Jan 05, 2026Jan 19, 2026Feb 02, 2026Feb 16, 2026Mar 02, 2026Mar 16, 2026Mar 30, 2026Apr 13, 2026May 04, 2026May 18, 2026Jun 01, 2026Jun 15, 2026Jun 29, 2026Jul 20, 2026Aug 03, 2026Aug 17, 2026Aug 31, 2026Sep 14, 2026Sep 28, 2026Oct 12, 2026

Social Trend

Timberlyne Therapeutics had 3,155 followers as of October 12, 2026. The number of followers increased by 8 (0.25%) week-over-week.

3,155Latest Followers Count
8(0.25%)Week-Over-Week Change
01,0002,0003,0004,000Dec 22, 2025Jan 05, 2026Jan 19, 2026Feb 02, 2026Feb 16, 2026Mar 02, 2026Mar 16, 2026Mar 30, 2026Apr 13, 2026May 04, 2026May 18, 2026Jun 01, 2026Jun 15, 2026Jun 29, 2026Jul 20, 2026Aug 03, 2026Aug 17, 2026Aug 31, 2026Sep 14, 2026Sep 28, 2026Oct 12, 2026

Funding Round

Funding DateFunding RoundAmount RaisedPost-Money Valuation
Jan 10, 2025Series A$180.00M―

Investors

Similar Companies

A snapshot of private companies similar to Timberlyne Therapeutics, helping you discover and navigate related company profiles.

Related News and Analysis